Jun 18, 2012, 03.24 PM | Source: Moneycontrol.com
Piramal Healthcare is in talk to buy US based healthcare company called Cambridge Major Labs for USD 200 million, reports Business Line.
Piramal Healthcare touched an intraday high of Rs 492 and an intraday low of Rs 481. At 09:59 hrs the share was quoting at Rs 490, up Rs 4.50, or 0.93%.
It was trading with volumes of 3,542 shares. In the previous trading session, the share closed up 3.13% or Rs 14.75 at Rs 485.50.
The company's trailing 12-month (TTM) EPS was at Rs 20.75 per share. (Mar, 2012). The stock's price-to-earnings (P/E) ratio was 23.57. The latest book value of the company is Rs 685.56 per share. At current value, the price-to-book value of the company was 0.71. The dividend yield of the company was 2.45%.
"Piramal Enterprises through its structured invest
Piramal Enterprises, through its Structured Invest
Nooresh Merani of Asian Market Securities is of th
Piramal Enterprises has informed that at the Meeti
The meeting of committee of directors (Funding) to
The drugmaker, based in the southern Indian city o
Josh Earnest said this when asked about the report
Launched by Atlantic Council yesterday, the initia